Hemanext ONE is the first meaningful FDA-authorized processing and storage technology proven to mitigate the red blood cell (RBC) storage lesion.1-4
Transforming Red Blood Cells Advancing Care.
Hemanext is a global biomedical technology pioneer in transfusion medicine. We recognize the vital role of blood for patients and are committed to optimizing its therapeutic impact and value to the healthcare system. Focused on the study of hypoxically stored RBCs, our research and development efforts aim to significantly improve the quality of stored RBCs worldwide. We strive to achieve our mission of delivering innovations that improve the standard of care for patients who rely on transfusions by transforming RBCs through protecting their quality, functionality, and viability during storage.
Latest News and Events
Hemanext Inc. Announces a Significant Milestone with FDA Marketing Authorization for Hemanext ONE®, Hemanext’s Innovative Red Blood Cell (RBC) Processing and Storage System
Hemanext ONE has been granted marketing authorization for commercial distribution via the De Novo process by the U.S. Food and Drug Administration (FDA) LEXINGTON, Mass., September 21, 2023, –Hemanext Inc., a leading innovator in blood processing, storage, and...
Hemanext Announces Founder Martin Cannon’s Retirement, Appoints Andrew Dunham as CEO, and Raises Funding for Growth
LEXINGTON, Mass., September 18, 2023, – Hemanext Inc., a leading innovator in blood processing, storage, and transfusion technology, marks a significant turning point in its history as the company announces the retirement of its founder, Martin Cannon. Simultaneously,...
Hemanext Announces Membership in European Confederation of Pharmaceutical Entrepreneurs (EUCOPE)
LEXINGTON, Mass., July 5, 2023, – Hemanext Inc., a leading innovator in blood processing, storage, and transfusion technology, today announced its membership in the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE), the region's premier trade association...
Hemanext Announces a Strategic Partnership and Investment from Vitalant
Partnership to include research and development at Vitalant Innovation Center LEXINGTON, Mass., June 7, 2023, –Hemanext Inc., a leading innovator in blood processing, storage, and transfusion technology, today announced a new partnership with Vitalant, one of the...
Hemanext Continues European Rollout of Hemanext ONE® RBC Processing and Storage System
Groundbreaking technology to be deployed to transfuse thalassemia patients in Italy and acute bleeding burn patients in Norway LEXINGTON, Mass., May 25, 2023, –Hemanext Inc., a leading innovator in blood processing, storage, and transfusion technology, today announced...
Hemanext Research
Learn more about Hemanext and take a closer look at our publications, studies, and posters focused on blood quality and red blood cell characterization.